Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Davidson

Showing results (301-310 of 358) with videos related to

Pageof 36
Sort By:
BMC Health Services Research|November 23, 2019
Adult mental health provision in England: a national survey of acute day unitsDanielle Lamb, Michael Davidson, Brynmor Lloyd-Evans, et al.
JAMA|July 2, 2002
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)Deborah Grady, David Herrington, Vera Bittner, et al.
Lung Cancer (Amsterdam, Netherlands)|January 27, 2022
A pilot of Blood-First diagnostic cell free DNA (cfDNA) next generation sequencing (NGS) in patients with suspected advanced lung cancerWanyuan Cui, Charlotte Milner-Watts, Terri P McVeigh, et al.
The American Journal of Cardiology|November 6, 2013
Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart diseaseAntonio M Gotto, Christopher P Cannon, Xiujiang Susie Li, et al.
Lancet (London, England)|May 20, 2021
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trialPaul M Ridker, Matt Devalaraja, Florian M M Baeres, et al.
Schizophrenia Research|June 27, 2006
A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalizationSteven G Potkin, Georges M Gharabawi, Andrew J Greenspan, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 5, 2009
Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, NiceGuy Goodwin, Wolfgang Fleischhacker, Celso Arango, et al.
Biology Open|May 6, 2020
A novel and cost-effective <i>ex vivo</i> orthotopic model for the study of human breast cancer in mouse mammary gland organ cultureAkash Gupta, Geetanjali Gupta, Rajeshwari R Mehta, et al.
JAMA Psychiatry|August 1, 2019
Effect of Adjunctive Estradiol on Schizophrenia Among Women of Childbearing Age: A Randomized Clinical TrialMark Weiser, Linda Levi, Daisy Zamora, et al.
Cardiology Clinics|November 26, 2008
Extended-release niacin/laropiprant: reducing niacin-induced flushing to better realize the benefit of niacin in improving cardiovascular risk factorsJohn F Paolini, Harold E Bays, Christie M Ballantyne, et al.
Pageof 36

Showing results (301-310 of 358) with videos related to

Sort By:
Pageof 36
BMC Health Services Research|November 23, 2019
Adult mental health provision in England: a national survey of acute day unitsDanielle Lamb, Michael Davidson, Brynmor Lloyd-Evans, et al.
JAMA|July 2, 2002
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)Deborah Grady, David Herrington, Vera Bittner, et al.
Lung Cancer (Amsterdam, Netherlands)|January 27, 2022
A pilot of Blood-First diagnostic cell free DNA (cfDNA) next generation sequencing (NGS) in patients with suspected advanced lung cancerWanyuan Cui, Charlotte Milner-Watts, Terri P McVeigh, et al.
The American Journal of Cardiology|November 6, 2013
Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart diseaseAntonio M Gotto, Christopher P Cannon, Xiujiang Susie Li, et al.
Lancet (London, England)|May 20, 2021
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trialPaul M Ridker, Matt Devalaraja, Florian M M Baeres, et al.
Schizophrenia Research|June 27, 2006
A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalizationSteven G Potkin, Georges M Gharabawi, Andrew J Greenspan, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 5, 2009
Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, NiceGuy Goodwin, Wolfgang Fleischhacker, Celso Arango, et al.
Biology Open|May 6, 2020
A novel and cost-effective <i>ex vivo</i> orthotopic model for the study of human breast cancer in mouse mammary gland organ cultureAkash Gupta, Geetanjali Gupta, Rajeshwari R Mehta, et al.
JAMA Psychiatry|August 1, 2019
Effect of Adjunctive Estradiol on Schizophrenia Among Women of Childbearing Age: A Randomized Clinical TrialMark Weiser, Linda Levi, Daisy Zamora, et al.
Cardiology Clinics|November 26, 2008
Extended-release niacin/laropiprant: reducing niacin-induced flushing to better realize the benefit of niacin in improving cardiovascular risk factorsJohn F Paolini, Harold E Bays, Christie M Ballantyne, et al.
Pageof 36